Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Chem Biol ; 18(3): 314-23, 2011 Mar 25.
Article in English | MEDLINE | ID: mdl-21439476

ABSTRACT

Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (γc) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression. Jak1 cooperates with Jak3 in signaling through γc-containing receptors. Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors. We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system. The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation. Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor. Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.


Subject(s)
Janus Kinase 1/metabolism , Janus Kinase 3/metabolism , Receptors, Cytokine/metabolism , Signal Transduction , Animals , Cell Line , Humans , Interleukin-2/pharmacology , Janus Kinase 1/antagonists & inhibitors , Janus Kinase 1/genetics , Janus Kinase 3/antagonists & inhibitors , Janus Kinase 3/genetics , Mice , Mutation , Phosphorylation , Protein Kinase Inhibitors/pharmacology , RNA Interference , RNA, Small Interfering , Receptors, Cytokine/chemistry , STAT5 Transcription Factor/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...